Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes
- PMID: 36706789
- DOI: 10.1111/1471-0528.17412
Uterine-preserving treatments or hysterectomy reintervention after myomectomy or uterine artery embolisation: A retrospective cohort study of long-term outcomes
Abstract
Objective: To assess comparative rates of further uterine-preserving procedures (UPP) or hysterectomy reintervention, after myomectomy or uterine artery embolisation (UAE).
Design: Population-based, retrospective cohort study.
Setting: England.
Population: Women who underwent myomectomy or UAE between 2010 and 2015 under the NHS.
Methods: Data was abstracted from NHS Health Episode Statistics datasets. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using Cox proportional-hazards regression.
Main outcomes measures: 30-day readmission, UPP and hysterectomy reintervention rates.
Results: 9443 and 6224 women underwent elective myomectomy or UAE, respectively. After 118 136 total person-years of follow-up, the rate of hysterectomy was 8.34 and 20.98 per 1000 patient years for myomectomy or UAE, respectively. There was a 2.4-fold increased risk of undergoing hysterectomy after UAE when compared with myomectomy in adjusted models (HR 2.38 [95% CI 2.10-2.66]) [adjusted for age, ethnicity, multiple deprivation index, geographical region and comorbidities]. The HR for undergoing a UPP reintervention was 1.44 (95% CI 1.29-1.60) in favour of myomectomy. The rate of hysterectomy was increased 22% following UAE compared with laparoscopic myomectomy (0.97-1.52). Age may influence reintervention rates, and there was variation in hysterectomy risk when stratified by geographical region.
Conclusions: After a median of 7 years of follow-up, there is a 2.4-fold increased rate of hysterectomy and 44% increased risk of UPPs as reintervention after UAE, relative to myomectomy. These findings will aid pre-procedure counselling for women with fibroids. Future work should investigate the effect of other outcome modifiers, such as fertility intentions and fibroid anatomical characteristics.
Keywords: fibroids; leiomyomas; myomectomy; uterine artery embolisation.
© 2023 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
Comment in
-
The pitfalls of retrospective analysis when assessing long-term outcomes for women with fibroids.BJOG. 2023 Oct;130(11):1430-1431. doi: 10.1111/1471-0528.17585. Epub 2023 Jun 27. BJOG. 2023. PMID: 37366018 No abstract available.
References
REFERENCES
-
- Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-12.
-
- Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100-7.
-
- Wegienka G, Stewart EA, Nicholson WK, Zhang S, Li F, Thomas L, et al. Black women are more likely than white women to schedule a uterine-sparing treatment for Leiomyomas. J Womens Health. 2021;30(3):355-66.
-
- Strand T, Kives S, Leyland N, Ashkenas J, Janiszewski P, Thiel J. Treatment choices in a National Cohort of Canadian women with symptomatic uterine fibroids. J Obstet Gynaecol Can. 2020;42(12):1475-82.e2.
-
- Amoah A, Joseph N, Reap S, Quinn SD. Appraisal of national and international uterine fibroid management guidelines: a systematic review. BJOG. 2022;129(3):356-64.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical